Phillips J O, Everson M P, Moldoveanu Z, Lue C, Mestecky J
Department of Microbiology, University of Alabama, Birmingham 35294.
J Immunol. 1990 Sep 15;145(6):1740-4.
The expression of secretory component (SC), the epithelial receptor for polymeric Ig, was enhanced by the addition of human rIFN-gamma or rIL-4, as revealed by the binding of radiolabeled polymeric, J chain-containing IgA or anti-SC antisera to the human colonic adenocarcinoma epithelial cell line HT-29. In combination, these cytokines exhibited a synergistic effect, and the potentiating effect of IL-4 was inhibitable by polyclonal anti-IL-4 antisera. Because the binding of radiolabeled polymeric IgA (pIgA) to HT-29 cells was inhibited by unlabeled pIgA or a polyclonal anti-SC reagent, but not by IgG, monomeric IgA, or Fab alpha fragments, we conclude that the receptor involved in the increased binding of pIgA is indeed SC. These data suggest that the expression of SC on human epithelial cells and the subsequent binding of pIgA (produced in mucosal tissues and glands by subepithelial plasma cells) is regulated by lymphokines such as IL-4 and IFN-gamma that are presumably derived from T cells found in abundant numbers in these tissues. These findings demonstrate a novel pathway of interaction between T cell products and epithelial cells that may result in enhanced translocation of large amounts of locally produced pIgA through epithelial cells into external secretions.
如放射性标记的含J链的聚合型IgA或抗分泌成分(SC)抗血清与人结肠腺癌上皮细胞系HT-29的结合所示,添加人重组干扰素-γ(rIFN-γ)或重组白细胞介素-4(rIL-4)可增强聚合型Ig的上皮受体——分泌成分(SC)的表达。这些细胞因子联合使用时表现出协同效应,且IL-4的增强作用可被多克隆抗IL-4抗血清抑制。由于未标记的聚合型IgA(pIgA)或多克隆抗SC试剂可抑制放射性标记的pIgA与HT-29细胞的结合,但IgG、单体IgA或Fabα片段则无此作用,我们得出结论,参与pIgA结合增加的受体确实是SC。这些数据表明,人上皮细胞上SC的表达以及随后pIgA(由上皮下浆细胞在黏膜组织和腺体中产生)的结合受细胞因子如IL-4和IFN-γ的调节,这些细胞因子可能来自这些组织中大量存在的T细胞。这些发现证明了T细胞产物与上皮细胞之间一种新的相互作用途径,这可能导致大量局部产生的pIgA通过上皮细胞增强转运至外分泌液中。